Moderna's Company History FOUNDING YEAR: 2010 TEAM MEMBERS: 820+ (As of December, 2019) Current Job Openings > HEADQUARTERS: Cambridge, MA CEO: Stéphane Bancel Learn About Stéphane > LOCATIONS: 200 Technology Square, Cambridge, MA 500 Technology Square, Cambridge, MA One Upland Road, Norwood, MA SPACE: 200,000 Sq Ft: R&D, New Venture Labs, and corporate offices in Cambridge, MA 200,000 Sq Ft: GMP mRNA clinical manufacturing facility in Norwood, MA THERAPEUTIC AREAS: Infectious Diseases Immuno-Oncology Rare Diseases Cardiovascular Diseases Autoimmune Diseases CAPITALIZATION: Cash, cash equivalents, and investments in marketable securities: $1.26 billion (unaudited, December 31, 2019) Total cash raised (Financing & Partners): $3.2B Potential $184 million (as of December 31, 2019): BARDA, DARPA, Bill & Melinda Gates Foundation No Debt PARTNERS: PIPELINE: 21 development candidates; 13 in clinical studies View Our Pipeline > FOUNDING INVESTOR: Flagship Pioneering Last Updated: January 2020
| Recipient | Total | Donors |
|---|---|---|
| Bill Nelson | $500 | Paul Sagan |
| Bill Richardson | $500 | Paul Sagan |
| John Joseph Moakley | $500 | Henri A Termeer |
| Patrick Murphy | $250 | Paul Sagan |
| Kirsten Gillibrand | $250 | Paul Sagan |
| Peter I Blute | $250 | Henri A Termeer |
| Types | Organization, Business, Public Company |
| Start date | 2010 |
| Website | https://www.modernatx.com/ |
| Aliases | Moderna Therapeutics |